Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,582,446 | 1,526,606 | 1,945,173 | 2,121,278 | 2,027,610 |
| Marketable Securities | N/A | N/A | 0 | N/A | 2,250 |
| Receivables | 478,156 | 454,993 | 109,961 | 71,363 | 102,193 |
| Inventories | 106,648 | 8,872 | N/A | N/A | N/A |
| TOTAL | $2,347,405 | $2,155,119 | $2,174,181 | $2,354,992 | $2,246,784 |
| Non-Current Assets | |||||
| PPE Net | 247,213 | 225,741 | 214,751 | 213,186 | 192,044 |
| Intangibles | 135,291 | 131,479 | 137,016 | 139,575 | 136,149 |
| Other Non-Current Assets | 104,966 | 64,414 | 39,993 | 41,834 | 33,389 |
| TOTAL | $487,470 | $421,634 | $391,760 | $394,595 | $361,582 |
| Total Assets | $2,834,875 | $2,576,753 | $2,565,941 | $2,749,587 | $2,608,366 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 135,128 | 127,050 | 59,564 | 73,995 | 113,605 |
| Accrued Expenses | 559,876 | 673,731 | 323,867 | 249,178 | 148,611 |
| Other current liabilities | 31,271 | 36,061 | 3,637 | 9,887 | 2,386 |
| TOTAL | $2,261,005 | $2,390,319 | $1,753,415 | $1,651,516 | $1,208,555 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,094,232 | 1,422,944 | 1,262,360 | 1,220,073 | 822,809 |
| Other Non-Current Liabilities | 66,798 | 365,579 | 351,190 | 343,316 | 343,988 |
| TOTAL | $508,546 | $538,107 | $351,190 | $352,509 | $360,684 |
| Total Liabilities | $2,769,551 | $2,928,426 | $2,104,605 | $2,004,025 | $1,569,239 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,135 | 76,283 | 75,608 | 74,484 | 74,094 |
| Common Shares | 787 | 764 | 760 | 747 | 745 |
| Retained earnings | -3,414,542 | -3,617,950 | -2,771,666 | -2,449,235 | -2,096,918 |
| Other shareholders' equity | -1,213 | -1,454 | 729 | 3,965 | -814 |
| TOTAL | $65,324 | $-351,673 | $461,336 | $745,562 | $1,039,127 |
| Total Liabilities And Equity | $2,834,875 | $2,576,753 | $2,565,941 | $2,749,587 | $2,608,366 |